Pediatric abdominal tumors: Neuroblastoma

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Abstract

Key Points: □ The clinical presentation of neuroblastoma can be nonspecific and sometimes confusing (strong evidence). □ The features that need to be evaluated on imaging studies for surgical planning or staging in neuroblastoma are tumor location, regional tumor extent (including vascular encasement, midline extension, regional lymph node involvement), and skeletal or liver metastases (strong evidence). □ Ultrasonography, computed tomography (CT), and magnetic resonance imaging (MRI) have high sensitivity for tumor detection and moderate specificity (strong evidence). □ CT and MRI have moderate sensitivity for detection of regional tumor extent and are superior to sonography for this determination (limited to moderate evidence). □ MRI, bone scintigraphy, metaiodobenzylguanidine (MIBG) scintigraphy and fluoro-2-deoxy-d-glucose positron emission (FDG-PET) imaging have high sensitivity for detecting bone/bone marrow metastases (moderate to strong evidence). □ MRI, MIBG scintigraphy, and FDG-PET imaging have high sensitivity for detecting non-skeletal metastases (moderate to strong evidence). □ No data were found in the medical literature that evaluate the cost-effectiveness of the different imaging modalities in the evaluation of these tumors.

Original languageEnglish
Title of host publicationEvidence-Based Imaging in Pediatrics
Subtitle of host publicationOptimizing Imaging in Pediatric Patient Care
PublisherSpringer New York
Pages509-524
Number of pages16
ISBN (Print)9781441960801
DOIs
StatePublished - Dec 1 2010

Fingerprint Dive into the research topics of 'Pediatric abdominal tumors: Neuroblastoma'. Together they form a unique fingerprint.

  • Cite this

    Siegel, M. J. (2010). Pediatric abdominal tumors: Neuroblastoma. In Evidence-Based Imaging in Pediatrics: Optimizing Imaging in Pediatric Patient Care (pp. 509-524). Springer New York. https://doi.org/10.1007/978-1-4419-0922-0_34